Natural Alternatives International (NAII) Competitors $4.30 -0.12 (-2.71%) (As of 01:13 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends NAII vs. MTEX, VXRT, AVTX, CLLS, IPSC, MNPR, COYA, TLSA, ADAG, and MNOVShould you be buying Natural Alternatives International stock or one of its competitors? The main competitors of Natural Alternatives International include Mannatech (MTEX), Vaxart (VXRT), Avalo Therapeutics (AVTX), Cellectis (CLLS), Century Therapeutics (IPSC), Monopar Therapeutics (MNPR), Coya Therapeutics (COYA), Tiziana Life Sciences (TLSA), Adagene (ADAG), and MediciNova (MNOV). These companies are all part of the "pharmaceutical products" industry. Natural Alternatives International vs. Mannatech Vaxart Avalo Therapeutics Cellectis Century Therapeutics Monopar Therapeutics Coya Therapeutics Tiziana Life Sciences Adagene MediciNova Natural Alternatives International (NASDAQ:NAII) and Mannatech (NASDAQ:MTEX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, community ranking, risk, dividends, earnings and valuation. Which has more risk and volatility, NAII or MTEX? Natural Alternatives International has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Comparatively, Mannatech has a beta of 1.17, indicating that its share price is 17% more volatile than the S&P 500. Do insiders and institutionals believe in NAII or MTEX? 32.4% of Natural Alternatives International shares are held by institutional investors. Comparatively, 13.0% of Mannatech shares are held by institutional investors. 20.9% of Natural Alternatives International shares are held by company insiders. Comparatively, 41.5% of Mannatech shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community prefer NAII or MTEX? Mannatech received 52 more outperform votes than Natural Alternatives International when rated by MarketBeat users. Likewise, 76.31% of users gave Mannatech an outperform vote while only 75.37% of users gave Natural Alternatives International an outperform vote. CompanyUnderperformOutperformNatural Alternatives InternationalOutperform Votes25475.37% Underperform Votes8324.63% MannatechOutperform Votes30676.31% Underperform Votes9523.69% Is NAII or MTEX more profitable? Mannatech has a net margin of -1.26% compared to Natural Alternatives International's net margin of -7.53%. Natural Alternatives International's return on equity of -10.23% beat Mannatech's return on equity.Company Net Margins Return on Equity Return on Assets Natural Alternatives International-7.53% -10.23% -5.38% Mannatech -1.26%-15.62%-3.76% Does the media refer more to NAII or MTEX? In the previous week, Mannatech had 1 more articles in the media than Natural Alternatives International. MarketBeat recorded 1 mentions for Mannatech and 0 mentions for Natural Alternatives International. Natural Alternatives International's average media sentiment score of 0.00 beat Mannatech's score of -0.24 indicating that Natural Alternatives International is being referred to more favorably in the media. Company Overall Sentiment Natural Alternatives International Neutral Mannatech Neutral Which has stronger earnings and valuation, NAII or MTEX? Mannatech has higher revenue and earnings than Natural Alternatives International. Mannatech is trading at a lower price-to-earnings ratio than Natural Alternatives International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatural Alternatives International$113.80M0.24-$7.22M-$1.44-3.07Mannatech$131.96M0.12-$2.24M-$0.81-10.37 SummaryMannatech beats Natural Alternatives International on 10 of the 15 factors compared between the two stocks. Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Get Natural Alternatives International News Delivered to You Automatically Sign up to receive the latest news and ratings for NAII and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAII vs. The Competition Export to ExcelMetricNatural Alternatives InternationalMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$27.40M$1.26B$5.04B$8.81BDividend YieldN/AN/A5.16%4.07%P/E Ratio-3.0748.60130.5317.82Price / Sales0.248.671,183.8674.55Price / CashN/A11.9233.6132.53Price / Book0.332.174.684.68Net Income-$7.22M-$52.95M$119.23M$226.08M7 Day Performance-2.43%-3.61%-1.83%-1.04%1 Month Performance0.91%-3.14%-3.61%1.04%1 Year Performance-26.33%5.58%31.74%26.28% Natural Alternatives International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAIINatural Alternatives International0.3433 of 5 stars$4.30-2.7%N/A-27.8%$26.66M$113.80M-2.99290Analyst ForecastNews CoverageMTEXMannatech0.936 of 5 stars$8.40+4.3%N/A-15.5%$15.79M$131.96M0.00250Analyst ForecastGap UpHigh Trading VolumeVXRTVaxart2.1538 of 5 stars$0.60-1.1%$3.00+399.2%-22.1%$106.64M$7.38M-1.48109Analyst RevisionNews CoveragePositive NewsAVTXAvalo Therapeutics2.3663 of 5 stars$10.11-7.2%N/A-47.4%$105.04M$1.92M0.0040Positive NewsCLLSCellectis2.4726 of 5 stars$1.88-1.6%$7.00+272.3%-38.4%$104.49M$9.19M0.00290Analyst ForecastIPSCCentury Therapeutics1.5802 of 5 stars$1.23-2.8%$11.60+846.9%-11.9%$104.16M$2.23M0.00170MNPRMonopar Therapeutics3.5896 of 5 stars$19.52+2.7%$27.33+40.0%+1,213.5%$103.07MN/A0.0010COYACoya Therapeutics3.0537 of 5 stars$6.15+2.0%$16.67+171.0%+10.6%$102.77M$6M0.006TLSATiziana Life Sciences0.5465 of 5 stars$0.97-3.0%N/A+75.4%$102.20MN/A0.008Positive NewsADAGAdagene2.9813 of 5 stars$2.30+10.0%$5.00+117.4%+52.6%$101.82M$18.11M0.00260News CoveragePositive NewsGap UpMNOVMediciNova0.6713 of 5 stars$2.05+5.1%N/A-5.3%$100.50M$1M-9.2910News Coverage Related Companies and Tools Related Companies Mannatech Competitors Vaxart Competitors Avalo Therapeutics Competitors Cellectis Competitors Century Therapeutics Competitors Monopar Therapeutics Competitors Coya Therapeutics Competitors Tiziana Life Sciences Competitors Adagene Competitors MediciNova Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NAII) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natural Alternatives International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natural Alternatives International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NAII Stock Alerts